We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Influence of Metabolic Factors in Patients with Chronic Viral Hepatitis C Who Received Oral Antiviral Treatment.
- Authors
Gavril, Oana Irina; Gavril, Radu Sebastian; Mitu, Florin; Gavrilescu, Otilia; Popa, Iolanda Valentina; Tatarciuc, Diana; Drugescu, Andrei; Oprescu, Andrei Catalin; Gherasim, Andreea; Mihalache, Laura; Esanu, Irina Mihaela
- Abstract
Hepatic diseases pose a significant public health concern. Regardless of the severity of hepatic fibrosis, treatment is recommended for all chronic hepatitis C virus (HCV) subjects. However, fibrosis and steatosis assessment remains crucial for evaluating the prognosis, progression, and hepatic disease monitoring, particularly following the treatment with direct-acting antivirals (DAAs). The aim of our study was to evaluate the impact of metabolic factors and the extent of hepatic fibrosis and fat accumulation in chronic HCV infection subjects. Additionally, another objective was to investigate modifications regarding fibrosis and steatosis three months after a successful sustained viral response (SVR). A total of 100 patients with compensated cirrhosis and chronic hepatitis C (CHC) were included in our study. These patients received treatment with DAA and underwent Fibromax assessment before and three months post SVR. After DAA treatment, a significant decrease was observed in the degree of hepatic fibrosis and hepatic steatosis. This regression was evident three months following the achievement of SVR. Chronic viral hepatitis C may trigger risk factors for metabolic syndromes, such as obesity and type 2 diabetes mellitus. Conclusions: It is crucial to monitor metabolic factors and take timely measures to prevent or treat metabolic syndrome in patients with chronic viral hepatitis C.
- Subjects
CHRONIC hepatitis C; HEPATIC fibrosis; FATTY liver; ORAL drug administration; HEPATITIS C virus
- Publication
Metabolites (2218-1989), 2023, Vol 13, Issue 4, p571
- ISSN
2218-1989
- Publication type
Article
- DOI
10.3390/metabo13040571